INS and pancreatic insulinoma: An indirect approach is to monitor autoantibodies against insulin, the insulinoma-associated tyrosine phosphatase- like protein (IA-2), the 65-kDa glutamic acid decarboxylase isoform (GAD65), and zinc transporter 8 (ZnT8) (30–33).